Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
This page compares total market funds for retirement in 2024, highlighting price efficiency, liquidity, and risk considerations.
28,534 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Apple introduces its most affordable devices to date, with price points starting at $599. The move targets price-cons...
Bitcoin steadies near the $70,000 mark as oil prices leap and geopolitical tensions rise. Analysts weigh whether the ...
A prompt-driven AI nicknamed Grok projects sharp gains for XRP, Bitcoin, and Ethereum by late 2026, even as oil-drive...
Analysts issued fresh upgrades on a slate of big-name stocks as earnings season continues. Applied Materials, Devon E...
XRP faces a divided market: ETF demand wanes and hodlers split on the near-term fate. The coin sits near a key suppor...
A Google software engineer is facing insider trading charges after allegedly using confidential internal data to prof...
A triple-leveraged note tied to a tech stock basket plunged 18% in a single session, erasing much of a year’s gains a...
Analysts weigh a path to $400 per share by 2028 as Apple rides iPhone demand and Services expansion, even as market h...
A WSJ investigation claims polymarket paid creators to stage fake winning bets on dummy sites, highlighting risks aro...
New disclosures reveal a mixed picture: five Fortune 500 holdings drew public commentary in 2026, while two media nam...
Rivian’s quality metrics, limited service footprint, and steep pricing are prompting investor caution in 2026. This r...